BridgeBio Pharma (BBIO) PT Lowered to $38 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.57 -0.03%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 17
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 3 | Down: 6 | New: 17
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on BridgeBio Pharma (NASDAQ: BBIO) to $38.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Yamazaki Baking (2212:JP) PT Lowered to JPY4,100 at UBS
- Trump announces nine more pharma firms in drug pricing deals
- BridgeBio to Participate in September Investor Conferences
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
